Search

Search results

2993 results found

Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies.

Mattei, P L, K C Corey, and A B Kimball. 2014. “Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): The Correlation Between Disease Severity and Psychological Burden in Patients Treated With Biological Therapies.”. Journal of the European Academy of Dermatology and Venereology : JEADV 28 (3): 333-7.

Incidence rates of malignancies and hospitalized infectious events in patients with psoriasis with or without treatment and a general population in the U.S.A.: 2005-09.

Kimball, A B, J Schenfeld, N A Accortt, M S Anthony, K J Rothman, and D Pariser. 2014. “Incidence Rates of Malignancies and Hospitalized Infectious Events in Patients With Psoriasis With or Without Treatment and a General Population in the U.S.A.: 2005-09.”. The British Journal of Dermatology 170 (2): 366-73.

Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR).

Strober, Bruce, Melinda Gooderham, Elke M G J de Jong, Alexa B Kimball, Richard G Langley, Nikita Lakdawala, Kavitha Goyal, et al. 2018. “Depressive Symptoms, Depression, and the Effect of Biologic Therapy Among Patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR).”. Journal of the American Academy of Dermatology 78 (1): 70-80.